4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-24-005480
CEO, CFO, Director acquired 6,642 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David CEO, CFO, Director | 2024-02-06 | Option exercise | +3,475 | 88,124 | D | ||
| Finley John David CEO, CFO, Director | 2024-02-06 | Option exercise | +3,167 | 91,291 | D | ||
| Derivatives | |||||||
| Finley John David CEO, CFO, Director | 2024-02-06 | Option exercise · Restricted Stock Units | −3,475 | 27,800 | D | ||
| Finley John David CEO, CFO, Director | 2024-02-06 | Option exercise · Restricted Stock Units | −3,167 | 34,833 | D | ||
Loading xslF345X05/ownership.xml…